We'll call the meeting to order.
I want to thank the members, the ones who are here, for being here on time. The others I'm sure will be here very shortly.
We're into our last meeting with witnesses on the study on the common drug review, pursuant to Standing Order 108(2), a study on prescription drugs, the common drug review.
We want to make sure that we let everyone know and realize that this is leg one of a study on prescription drugs. We'll be getting into further studies after we issue a report on this. This is our last set of witnesses on the common drug review before we discuss and present the recommendations and a report to Parliament.
To wrap this up, we have with us John Wright from the Conference of Deputy Ministers of Health. It's good to have you here as co-chair and as Deputy Minister of Health, Government of Saskatchewan. And from the Canadian Agency for Drugs and Technologies in Health, it's good to have Jill Sanders, chief executive officer, with us. You're the two presenters.
We'll start with Mr. Wright. The floor is yours.